cblE Type of homocystinuria due to methionine synthase reductase deficiency: Functional correction by minigene expression

The cblE type of homocystinuria is a rare autosomal recessive disorder caused by impaired reductive activation of methionine synthase. Although earlier biochemical studies proposed that the methionine synthase enzyme might be activated by two different reducing systems, mutations were reported in only the methionine synthase reductase gene (MTRR) in cblE patients. The pathogenicity of MTRR mutations, however, has not yet been tested functionally. We report on nine patients of European origin affected by the cblE type of homocystinuria. They presented between 2 weeks and 3 years of age (median age 4 weeks) with anemia, which was macrocytic in only three patients, and with neurological involvement in all but two cases. Bone marrow examination performed in seven patients showed megaloblastic changes in all but one of them. All patients exhibited moderate to severe hyperhomocysteinemia (median plasma total homocysteine [Hcy] 92 μmol/L, range 44–169), while clearly reduced methionine was observed only in four cases. Pathogenic mutations were identified in both parental alleles of the MTRR gene in all patients. Five known (c.903+469T>C, c.1361C>T, c.1459G>A, c.1557‐4_1557+3del7, and c.1622_1623dupTA) and three novel mutations (c.7A>T, c.1573C>T, and c.1953‐6_1953‐2del5) were detected. Importantly, transfection of fibroblasts of cblE patients with a wild‐type MTRR minigene expression construct resulted in a significant approximately four‐fold increase of methionine synthesis, indicating correction of the enzyme defect. Our study shows a link between a milder predominantly hematological presentation and homozygosity for the c.1361C>T mutation, but no other obvious genotype‐phenotype correlation. The identification of mutations in the MTRR gene, together with restoration of methionine synthesis following MTRR minigene expression in cblE cells confirms that this disease is caused by defects in the MTRR gene. Hum Mutat 25:239–247, 2005. © 2005 Wiley‐Liss, Inc.

[1]  R. Banerjee,et al.  Redundancy in the Pathway for Redox Regulation of Mammalian Methionine Synthase , 2003, Journal of Biological Chemistry.

[2]  J. Zvárová,et al.  Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery disease. , 2003, Molecular genetics and metabolism.

[3]  T. Suormala,et al.  CblE type of homocystinuria: Mild clinical phenotype in two patients homozygous for a novel mutation in the MTRR gene , 2003, Journal of Inherited Metabolic Disease.

[4]  T. Suormala,et al.  CblE type of homocystinuria due to methionine synthase reductase deficiency: Clinical and molecular studies and prenatal diagnosis in two families , 2002, Journal of Inherited Metabolic Disease.

[5]  J. Zvárová,et al.  Essential hypertension in adolescents: association with insulin resistance and with metabolism of homocysteine and vitamins. , 2002, American journal of hypertension.

[6]  G. Boers,et al.  Vascular Outcome in Patients With Homocystinuria due to Cystathionine &bgr;-Synthase Deficiency Treated Chronically: A Multicenter Observational Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[7]  R. Banerjee,et al.  Human Methionine Synthase Reductase, a Soluble P-450 Reductase-like Dual Flavoprotein, Is Sufficient for NADPH-dependent Methionine Synthase Activation* , 2001, The Journal of Biological Chemistry.

[8]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[9]  S. Scherer,et al.  Molecular cloning, expression and physical mapping of the human methionine synthase reductase gene. , 1999, Gene.

[10]  D. Leclerc,et al.  Molecular basis for methionine synthase reductase deficiency in patients belonging to the cblE complementation group of disorders in folate/cobalamin metabolism. , 1999, Human molecular genetics.

[11]  R. Rozen,et al.  A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. , 1999, Molecular genetics and metabolism.

[12]  M. Culbertson,et al.  RNA surveillance. Unforeseen consequences for gene expression, inherited genetic disorders and cancer. , 1999, Trends in genetics : TIG.

[13]  R. Banerjee,et al.  Purification of Soluble Cytochrome b 5 as a Component of the Reductive Activation of Porcine Methionine Synthase* , 1998, The Journal of Biological Chemistry.

[14]  Aaron D. Wilson,et al.  Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Schutgens,et al.  Folate-responsive homocystinuria and megaloblastic anaemia in a female patient with functional methionine synthase deficiency (cblE disease) , 1997, Journal of Inherited Metabolic Disease.

[16]  R. Banerjee,et al.  Defects in Auxiliary Redox Proteins Lead to Functional Methionine Synthase Deficiency* , 1997, The Journal of Biological Chemistry.

[17]  S. Waisbren,et al.  Social factors and the meaning of food in adherence to medical diets: results of a maternal phenylketonuria summer camp , 1997, Journal of Inherited Metabolic Disease.

[18]  B. Shane,et al.  Human Methionine Synthase , 1997, The Journal of Biological Chemistry.

[19]  P. Goyette,et al.  Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/cobalamin disorders. , 1996, Human molecular genetics.

[20]  R. Banerjee,et al.  Cloning, mapping and RNA analysis of the human methionine synthase gene. , 1996, Human molecular genetics.

[21]  Keith Dudley Short protocols in molecular biology , 1990 .

[22]  D. Watkins,et al.  Functional methionine synthase deficiency (cblE and cblG): clinical and biochemical heterogeneity. , 1989, American journal of medical genetics.

[23]  D. Watkins,et al.  Genetic heterogeneity among patients with methylcobalamin deficiency. Definition of two complementation groups, cblE and cblG. , 1988, The Journal of clinical investigation.

[24]  F. Lindgärde,et al.  Higher total plasma homocysteine in vitamin B12 deficiency than in heterozygosity for homocystinuria due to cystathionine beta-synthase deficiency. , 1988, Metabolism: clinical and experimental.

[25]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[26]  D. Rosenblatt,et al.  Altered vitamin B12 metabolism in fibroblasts from a patient with megaloblastic anemia and homocystinuria due to a new defect in methionine biosynthesis. , 1984, The Journal of clinical investigation.

[27]  K. Jha,et al.  Efficient transfer of cloned DNA into human diploid cells: protoplast fusion in suspension , 1984, Molecular and cellular biology.

[28]  B. Fowler,et al.  Methionine and Serine Formation in Control and Mutant Human Cultured Fibroblasts: Evidence for Methyl Trapping and Characterization of Remethylation Defects , 1997, Pediatric Research.

[29]  D. Rosenblatt Inherited Disorders of Folate and Cobalamin , 1997 .

[30]  Y. Sako,et al.  Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. , 1987, Journal of chromatography.

[31]  K. Pettigrew,et al.  The natural history of homocystinuria due to cystathionine beta-synthase deficiency. , 1985, American journal of human genetics.